Details for New Drug Application (NDA): 210166
✉ Email this page to a colleague
The generic ingredient in MOTEGRITY is prucalopride succinate. One supplier is listed for this compound. Additional details are available on the prucalopride succinate profile page.
Summary for 210166
Tradename: | MOTEGRITY |
Applicant: | Takeda Pharms Usa |
Ingredient: | prucalopride succinate |
Patents: | 0 |
Pharmacology for NDA: 210166
Mechanism of Action | Serotonin 4 Receptor Agonists |
Suppliers and Packaging for NDA: 210166
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-546 | 54092-546-01 | 30 TABLET, FILM COATED in 1 BOTTLE (54092-546-01) |
MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-547 | 54092-547-01 | 30 TABLET, FILM COATED in 1 BOTTLE (54092-547-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Dec 14, 2018 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Dec 14, 2018 | TE: | RLD: | Yes |
Complete Access Available with Subscription